[Symptomatic treatment of myotonias with intravenous administration of local anesthetics (procaine & panthesin)].
D061605:Administration, Intravenous; D062365:Aminobenzoates / Q000627:therapeutic use*; D000779:Anesthetics, Local; D002317:Cardiovascular Agents; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives; D009222:Myotonia; D009224:Myotonia Congenita / Q000628:therapy*; D009223:Myotonic Dystrophy / Q000628:therapy*; D011343:Procaine / Q000627:therapeutic use*; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D000779:Anesthetics, Local; D002317:Cardiovascular Agents; D062366:para-Aminobenzoates; D011343:Procaine; C005426:leucinocaine mesylate; D007930:Leucine
AMINOBENZOATES/therapeutic use; MYOTONIA ATROPHICA/therapy; MYOTONIA CONGENITA/therapy; PROCAINE/therapeutic use
Die symptomatische Behandlung der Myotonien mit intravenös verabreichten lokalanästhetischen Mitteln (Procain und Panthesin).